The Spanish Troop and Sailor Association (ATME) reported that the soldier began experiencing severe headaches and discomfort immediately after getting the vaccine; he attended a first-aid clinic and emergency unit on his base before being admitted to University Clinic of Navarra in a very serious condition a week after receiving the jab.
The province's top doctor said Friday that the patient is a man in his 60s who had received his first dose.
Dr. David Williams says the man has been treated and is recovering at home.
Ontario has confirmed its first case of a rare blood clot linked to the AstraZeneca COVID-19 vaccine.
From over 1.15 million vaccine doses administered in the State, the HPRA has received 6,616 reports of suspected side effects, the vast majority described as mild to moderate, adding the benefits of the vaccines continue to outweigh the risks.
After blood clots appeared in patients elsewhere in the world, the National Advisory Committee on Immunization recommended the AstraZeneca shot only be given to those over the age of 55.
He says these serious reactions remain extremely rare but they will monitor the evolving situation.
It recommended people be offered the AstraZeneca shot if they do not want to wait for an mRNA vaccine such as Pfizer or Moderna.
In Ontario, AstraZeneca was just made available to those 40 and older this week.
Health Canada has approved the vaccine and has said the benefits outweigh the risks.
During his daily COVID-19 briefing on Thursday, the Health Minister explained that the second dose of the three vaccines the local authorities are using in the current vaccination rollout is given at various times. "Ontarians are encouraged to get vaccinated as soon as they are eligible and monitor their health after receiving their vaccination".